Target intelligence / Profile preview

SPRY domain-containing SOCS box protein 2 (SPSB2)

Target
SPSB2
Molecular classification
Other (Adaptor protein), Ubiquitin ligase–associated protein
01

Overview

SPRY domain-containing SOCS box protein 2 (SPSB2) is an adaptor protein characterized by a central SPRY (splA/ryanodine receptor) domain and a C-terminal SOCS (suppressor of cytokine signaling) box[1][6]. SPSB2 functions primarily as a component in a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex, mediating the ubiquitination and subsequent proteasomal degradation of specific protein substrates, most notably inducible nitric oxide synthase (iNOS/NOS2)[1][3][6]. By recruiting the E3 ligase complex to iNOS through its SPRY domain, SPSB2 helps limit nitric oxide (NO) accumulation and cellular toxicity in activated macrophages[2][3][6]. Genetic and biochemical studies indicate SPSB2 is an important negative regulator of innate immune signaling and may have relevance in modulating chronic or persistent infections by influencing host-pathogen interactions[2][3]. Alternative splicing of SPSB2 leads to multiple transcript variants, and the gene is located on chromosome 12p13[1].

Other names
GRCC9SSB2SSB-2Gene-rich cluster protein C9LOC105369632
02

Biological functions

Ubiquitination and proteasomal degradation of target proteinsNegative regulation of nitric oxide productionRegulation of immune response in macrophages
03

Disease associations

Immune-related disease (Innate immune signaling modulation)Congenital muscular dystrophy-dystroglycanopathy type A7Acute contagious conjunctivitis

Beyond the preview

Go deeper on SPRY domain-containing SOCS box protein 2 (SPSB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPRY domain-containing SOCS box protein 2 (SPSB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call